Deepexi Technology Co., Ltd. — Board/Management Information 2026

Jun 1, 2026

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this notice, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this notice.

Deepexi Technology Co., Ltd.

酒普科技股份有限公司

(A joint stock company incorporated in the People's Republic of China with limited liability)

(Stock code: 1384)

PROPOSED CHANGE OF REGISTERED ADDRESS OF THE COMPANY AND AMENDMENTS TO THE ARTICLES OF ASSOCIATION; AND PROPOSED APPOINTMENT OF AN INDEPENDENT NON-EXECUTIVE DIRECTOR AND RESIGNATION OF AN INDEPENDENT NON-EXECUTIVE DIRECTOR

This announcement is made by Deepexi Technology Co., Ltd. (the "Company", together with its subsidiaries, the "Group") pursuant to Rules 13.51(1) and 13.51(2) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules").

PROPOSED CHANGE OF REGISTERED ADDRESS OF THE COMPANY AND AMENDMENTS TO THE ARTICLES OF ASSOCIATION

The board of directors (the "Directors") of the Company (the "Board") hereby announces that, the Board has considered and approved a proposal to change the registered address of the Company from "Room 1001-1002, 10th Floor, Building 1, No. 62 Courtyard, Xueyuan South Road, Haidian District, Beijing" to "Room 101, 11th Floor, Building 5, No. Jia 2 Courtyard, Xisanhuan North Road, Haidian District, Beijing" (subject to final approval by the relevant administrative authorities), and to amend the articles of association of the Company (the "Articles of Association") accordingly due to the aforementioned change of the registered address. The proposed amendments to the Articles of Association are set forth below:

Original article	Amended article
The Company’s domicile is: Room 1001-1002, 10th Floor, Building 1, No. 62 Courtyard, Xueyuan South Road, Haidian District, Beijing, PRC. Postal Code: 100081.	The Company’s domicile is: Room 101, 11th Floor, Building 5, No. Jia 2 Courtyard, Xisanhuan North Road, Haidian District, Beijing, Postal Code: 100089.

The proposed change of the registered address of the Company and the proposed amendments to the Articles of Association shall be subject to the approval by the Company's shareholders ("Shareholders") by a special resolution at the 2026 first extraordinary general meeting (the "EGM") to be convened by the Company.

A circular containing, among others, further details of the proposed change of the registered address of the Company and the proposed amendments to the Articles of Association, will be published on the websites of the Company and The Stock Exchange of Hong Kong Limited in due course.

---

PROPOSED APPOINTMENT OF AN INDEPENDENT NON-EXECUTIVE DIRECTOR

The Board hereby announces that, after taking into consideration the recommendation from the nomination committee of the Board, the Board has considered and approved the proposed appointment of Dr. Feng Wei (馮偉博士) (“Dr. Feng”) as an independent non-executive Director of the Company. The proposed appointment of Dr. Feng shall be subject to the approval by the Shareholders by an ordinary resolution at the EGM, and will take effect on the date of approval at the EGM.

Biographical details of Dr. Feng are set out below:

Dr. Feng Wei, aged 47, received a bachelor’s degree of engineering in computer science and technology from Northwestern Polytechnical University in July 2000, a master’s degree of engineering in computer science and technology from Northwestern Polytechnical University in April 2003, and a doctoral degree of engineering in computer science and technology from City University of Hong Kong in January 2008.

Dr. Feng has served as the Party Secretary and Dean of School of Computer Science and Technology of Tianjin University from September 2025 to present, and the chair professor of Tianjin University from January 2025 to present; served as the deputy director of College of Intelligence and Computing of Tianjin University from June 2018 to September 2025; served as the professor of Tianjin University from July 2016 to January 2025; served as an associate professor of Tianjin University from October 2010 to June 2016; conducted post-doctoral research in City University of Hong Kong from July 2009 to October 2010; and conducted post-doctoral research in The Chinese University of Hong Kong from January 2008 to July 2009.

Subject to the approval of appointment of Dr. Feng as the independent non-executive Director by the Shareholders at the EGM, the Company will enter into a letter of appointment with Dr. Feng. The term of office of Dr. Feng will commence from the date of approval of his appointment at the EGM and end upon the expiration of the term of the first session of the Board, and he may be re-elected upon the expiration of his term of office.

The Director’s remuneration of Dr. Feng is proposed to be HKD300,000 per annum, which is determined by the Board based on the recommendation from the remuneration and appraisal committee of the Board, with reference to his duties and responsibilities as well as prevailing market conditions, and will be reviewed by the remuneration and appraisal committee of the Board from time to time.

Dr. Feng has confirmed that (i) he meets each of the independence factors as set out in Rule 3.13(1) to (8) of the Listing Rules; (ii) he has no past or present financial or other interests in the business of the Company or its subsidiaries or any connection with any core connected person (as defined in the Listing Rules) of the Company; and (iii) there are no other factors that may affect his independence as of the date of this announcement. The Board also considers that Dr. Feng has the character, integrity, independence and professional experience required for the independent non-executive Director.

2

---

In recommending the appointment of Dr. Feng as an independent non-executive Director, the nomination committee has taken into account a variety of factors in accordance with the Board diversity policy adopted by the Company, including but not limited to gender, age, cultural and educational background, professional experience, skills, knowledge and length of service, aiming to achieve diversity of the Board. In assessing Dr. Feng’s proposed time and contributions devoted to the Board, as well as his ability to effectively perform his duties, the nomination committee has given particular consideration to the time he devoted to other significant external engagements, as well as factors or circumstances relating to his character, integrity, independence and experience. The nomination committee is of the view that Dr. Feng has extensive experience in computer science, artificial intelligence-related technologies, and higher education management, and his appointment will bring valuable expertise, independent opinions, and diverse perspectives to the Board, as well as contribute to enhancing the Company’s governance standards. Accordingly, the nomination committee recommended the proposed appointment of Dr. Feng as an independent non-executive Director to the Board after consideration.

Save as disclosed above, as at the date of this announcement, Dr. Feng (i) does not hold any positions with the Company or other members of the Group; (ii) did not hold any directorships in public companies listed on any securities market in Hong Kong or overseas in the last three years; (iii) does not have any relationships with any Directors, supervisors, senior management, substantial shareholders or controlling shareholders of the Company; and (iv) does not have any interest or short positions in any shares, underlying shares or debentures of the Company or any of its associated corporations within the meaning of Part XV of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong).

Save as disclosed above, there is no other information relating to the proposed appointment of Dr. Feng that shall be disclosed pursuant to Rule 13.51(2)(h) to (v) of the Listing Rules nor any other matters which need to be brought to the attention of the Shareholders.

A circular containing, among others, further details of the proposed appointment of Dr. Feng as an independent non-executive Director, together with the notice of the EGM, will be published on the websites of the Company and The Stock Exchange of Hong Kong Limited in due course.

RESIGNATION OF AN INDEPENDENT NON-EXECUTIVE DIRECTOR

The Board also announces that, due to personal work arrangements, Dr. Yang Hongxia (“Dr. Yang”) intends to resign as an independent non-executive Director of the Company and member of the audit committee, remuneration and appraisal committee and nomination committee of the Board. Such resignation will take effect from the date on which Dr. Feng is appointed as an independent non-executive Director.

Dr. Yang has confirmed that she has no disagreement with the Board and there is no matter relating to her proposed resignation that needs to be brought to the attention of the Shareholders and The Stock Exchange of Hong Kong Limited.

3

---

The Board would like to express its sincere gratitude to Dr. Yang for her valuable contributions to the Company during her tenure of office.

By Order of the Board
Deepexi Technology Co., Ltd.
Mr. Zhao Jiehui
Chairman of the Board, Executive Director and Chief Executive Officer

Beijing, the PRC
June 1, 2026

As at the date of this announcement, the Board of the Company comprises: (i) Mr. Zhao Jiehui, Mr. Yang Lei, Dr. Li Qiang, Mr. Cao Lianfei and Ms. Shi Yi as executive Directors; (ii) Mr. Wang Zhenghao as non-executive Director; and (iii) Dr. Yang Hongxia, Dr. Kong Xianguang and Mr. Zhang Jielong as independent non-executive Directors.

4